HOME HELP FEEDBACK TABLE OF CONTENTS ARCHIVE SUBSCRIPTIONS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Dawson, M. A. Articles by Cole-Sinclair, M. F. Search for Related Content PubMed PubMed Citation Articles by Dawson, M. A. Articles by Cole-Sinclair, M. F.

Blood transfusion requirements for patients undergoing chemotherapy for acute myeloid leukemia how much is enough?

^* Clinical Haematology/Bone Marrow Transplant Unit and Haematology Unit, Alfred Pathology Service, The Alfred Melbourne
^° Department of Epidemiology and Preventive Medicine, Monash University, The Alfred, Melbourne;
^# Australian Red Cross Blood Service, Melbourne, Victoria, Australia

Correspondence: Mark A. Dawson, The Alfred, Commercial Road, Melbourne, Victoria, Australia 3004. Phone: international +61.392762000. Fax: international +61.392763021. E-mail: dawsonm{at}ausdoctors.net

Although essential in the management of AML, there is little information quantitating transfusion requirements for these patients. We evaluated 111 consecutive adults treated for AML, showing that approximately 150 blood donors are required to adequately cater for a single patient’s complete therapy with little variation for age, prognostic group or intensity of treatment.

Key words: blood transfusion, chemotherapy, acute myeloid leukemia.